Drugs News and Research

RSS
Old antibiotic nitroxoline suggested as a treatment for MPOX

Old antibiotic nitroxoline suggested as a treatment for MPOX

New study to examine the effectiveness of stroke treatment for patients with disabilities

New study to examine the effectiveness of stroke treatment for patients with disabilities

Age-related macular degeneration reported to confer higher risk of severe SARS-CoV-2 infection

Age-related macular degeneration reported to confer higher risk of severe SARS-CoV-2 infection

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Want a clue on health care costs in advance? New tools take a crack at it

Want a clue on health care costs in advance? New tools take a crack at it

Mouse study identifies potential targets for treating dry eye disease and corneal injury

Mouse study identifies potential targets for treating dry eye disease and corneal injury

UKB resident awarded the C. E. Alken Prize for outstanding scientific uro-oncological research

UKB resident awarded the C. E. Alken Prize for outstanding scientific uro-oncological research

Study reveals novel role of PPARγ acetylation in macrophages in impairing adipose tissue function

Study reveals novel role of PPARγ acetylation in macrophages in impairing adipose tissue function

Study suggests a strategy for preventing the progression of chronic leukemia to aggressive disease

Study suggests a strategy for preventing the progression of chronic leukemia to aggressive disease

Scientists explore efficacy of small molecule drugs against severe COVID-19 in vitro

Scientists explore efficacy of small molecule drugs against severe COVID-19 in vitro

All patients with rheumatic disorders recommended to receive pneumococcal vaccine

All patients with rheumatic disorders recommended to receive pneumococcal vaccine

Enzyme that defends human cells against viruses may be a potential target for future cancer treatments

Enzyme that defends human cells against viruses may be a potential target for future cancer treatments

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

Scientists gain new insights into the opposing actions of serotonin-producing nerve fibers in mice

Scientists gain new insights into the opposing actions of serotonin-producing nerve fibers in mice

Scientists explore synthesis of griffithsin in cell-free systems

Scientists explore synthesis of griffithsin in cell-free systems

New test detects biomarker of Alzheimer's disease neurodegeneration in blood samples

New test detects biomarker of Alzheimer's disease neurodegeneration in blood samples

Insilico announces nomination of preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy

Insilico announces nomination of preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy

Wafer-thin device could drastically alter the course of treatment for Type 1 diabetes

Wafer-thin device could drastically alter the course of treatment for Type 1 diabetes

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Cost-effectiveness analysis of four interventions for treatment of cancer-associated thrombosis

Cell-based method can predict how breast cancer patients will respond to treatments

Cell-based method can predict how breast cancer patients will respond to treatments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.